OncoLink en espanõl
Share
Types of Cancer > Gynecologic Cancers > Ovarian Cancer > News
July 2009
Ovary removal may raise risk of lung cancer
Early menarche predicts decreased survival with ovarian cancer
Ultrasound superior to symptoms for predicting ovarian cancer
Hormone therapy linked to ovarian cancer
No pulmonary morbidity after diaphragm surgery for ovarian cancer
June 2009
Serum biomarker panel identifies early-stage ovarian cancer
Ovarian tissue transplant may restore fertility after cancer treatment
No benefit to treating ovarian cancer relapse based on rising CA125 alone
May 2009
Topotecan-docetaxel combo beneficial in heavily treated gynecologic cancer patients
April 2009
SNPs sharpen absolute risk estimates for prostate cancer
Synchronous ovarian and endometrial cancers linked with better outcomes
CRM197 enhances antitumor effect of paclitaxel in ovarian cancer
March 2009
Ovarian cancer screening fails to identify early disease
Glucose levels predict outcomes in ovarian carcinoma
CA125 and ultrasound effective for ovarian cancer screening
Additional chemo agent no benefit in advanced-stage ovarian cancer
Intraoperative chemotherapy in peritoneal cavity promising for ovarian cancer
February 2009
Annual screening for ovarian cancer in BRCA1/2 carriers deemed ineffective
Ovarian preservation appears safe in young endometrial cancer patients
December 2008
Oregovomab not effective for maintenance therapy in ovarian cancer
Silencing MYC oncogene has therapeutic potential in ovarian cancer
Plasma endoglin not useful marker in ovarian cancer
October 2008
U.S. says LabCorp ovarian cancer test sales illegal
September 2008
Trabectedin shows promise in recurrent ovarian cancer
August 2008
Symptom index plus CA 125 improves ovarian cancer detection
July 2008
Obesity increases risk of certain ovarian cancers
Risk of breast, ovarian cancer increased in infertile women
Topotecan combination no extra help in ovarian cancer
Risk of ovarian cancer is not reduced with analgesic use
June 2008
Ovarian stimulation with letrozole does not raise breast cancer recurrence risk
Aggressive care does not improve survival in late ovarian cancer
May 2008
Reproductive factors more tightly linked to premenopausal ovarian cancer
April 2008
Simultaneous operations feasible for hereditary breast-ovarian cancer syndrome
Ovarian serous carcinoma may originate in the fallopian tube
Mifepristone may improve cisplatin efficacy in ovarian cancer
March 2008
Ovarian cancer best treated at specialized hospitals in the Netherlands
February 2008
Thalidomide for recurrent ovarian cancer improves response
GnRH agonist reduces chemotherapy-induced ovarian failure
Blood test provides early detection of ovarian cancer
Androgens not associated with risk of ovarian cancer
January 2008
Caffeine linked to reduced incidence of ovarian cancer
Ultrasound quality strongly affects ovarian cancer management
Bevacizumab combination promising against ovarian cancer
Chronic inflammation not seen important in development of ovarian cancer
BRCA mutations tied to improved survival in Ashkenazi ovarian cancer patients
December 2007
Transvaginal ultrasound screening fails to detect early-stage ovarian cancer
November 2007
Paclitaxel-ceramide nanoparticulate overcomes drug resistance in ovarian cancer
Protective effect of OC use against ovarian cancer wanes after discontinuation
October 2007
Guidelines fail to identify most early stage ovarian cancers
September 2007
Age and other factors predict stage III ovarian cancer prognosis
July 2007
Survivors of ovarian germ cell tumors may retain fertility after surgery and chemo
Inhibin a potential marker of ovarian cancer in postmenopausal women
Ovarian cancer vaccine reinforces patient's immune response to tumor
June 2007
Lower limb lymphedema common in survivors of gynecological cancer
Anti-estrogen therapy promising in some ovarian cancers
Polycystic ovary syndrome appears to increase uterine leiomyomata risk
VEGF-Trap active in recurrent refractory advanced ovarian cancer
May 2007
Transvaginal sonographic screening may catch ovarian cancer early
Oophorectomy cuts breast, ovarian cancer risk for those with BRCA1/2 mutations
Symptoms common before ovarian cancer diagnosis in older women
April 2007
Ovarian cancer often under treated: study
Infertility drugs safe after borderline ovarian tumor treatment
March 2007
Supracervical hysterectomy alternative for ovarian cancer
Tumor vascular proteins may be biomarkers for ovarian cancer
Low-dose combination oral contraceptives protect against ovarian cancer
February 2007
Pain management at end of life seen inadequate in women with ovarian cancer
Pregnancy and oral contraceptives offer strongest anti-ovarian cancer effects
Absolute risk of second cancer small after hairy cell leukemia
January 2007
Lymphadenectomy improves survival in early ovarian cancer
First-line gemcitabine/carboplatin promising for advanced ovarian cancer
December 2006
Cisplatin and epirubicin combat germ cell tumors
Symptom screening may detect ovarian cancer earlier
November 2006
Ovarian ablation and chemotherapy comparable in breast cancer
Cell signaling protein correlates with ovarian cancer survival
CORRECTION: RF ablation may be useful in ovarian cancer metastatic to the liver
Polycystic-size ovaries common in healthy adolescents
LPAAT-beta an emerging prognostic, diagnostic, therapeutic target in ovarian cancer
October 2006
Benign ovarian cysts linked to lower breast cancer risk
Hormone therapy linked to ovarian cancer risk
Fanconi anemia gene suppression linked to familial ovarian cancer
September 2006
Poor ovarian cancer survival in black women not due to treatment differences
Family breast cancer history boosts ovarian cancer risk
August 2006
Obesity may make ovarian cancer more aggressive
Targeting focal adhesion kinase may lead to new ovarian cancer therapy
Optimistic ovarian cancer patients less distressed
Genetic evidence supports endometriosis as ovarian cancer precursor
July 2006
US OKs Lilly drug for ovarian cancer, spurns panel
Regular paracetamol/acetaminophen use may cut ovarian cancer risk
May 2006
Ovarian failure relatively rare after childhood cancer
IL-18 and FGF-2 complement CA125 in detecting ovarian cancer
April 2006
Pre-maintenance CA-125 level predicts risk of ovarian cancer relapse
Sedentary women may have increased ovarian cancer risk
Src inhibition a promising therapeutic approach to ovarian cancer
March 2006
Gemzar no help for ovarian cancer: US FDA staff
February 2006
Surgery by gynecologic oncologist improves ovarian cancer survival
Aspirin derivative active against cisplatin-resistant ovarian cancer cells
High levels of dairy foods may increase ovarian cancer risk
January 2006
Gynecologic oncologists have better outcomes than surgeons treating ovarian cancer
Surgery reduces gynecologic cancer risk in Lynch syndrome patients
Analgesic drug use may cut risk of ovarian cancer
Aggressive surgery improves survival in advanced ovarian cancer
BRCA1, BRCA2 mutations underestimated in ovarian cancer
December 2005
Ovaries safely retained after treatment of low-grade endometrial stromal sarcoma
November 2005
Glucose-sensitive PET points to ovarian cancer response
Physical activity may protect against ovarian cancer
October 2005
EGFR blocker and photodynamics combat ovarian cancer
Earlier diagnosis of ovarian cancer possible with pelvic imaging/CA125
Preoperative CA-125 level predicts outcome in stage I ovarian cancer
Ovarian malignancy commonly coexists with endometrial cancer in young women
September 2005
Family history common in women with breast or ovarian carcinoma
Genentech halts Avastin ovarian cancer trial
Familial ovarian cancer screening approach may be flawed
Repressor splicing factor gene stimulates ovarian cancer
August 2005
LHRH peptide targets chemotherapy to ovarian cancer cells
Abdominal swelling and pain commonly precede ovarian cancer diagnosis
High intake of milk, lactose may raise ovarian cancer risk
July 2005
Absorbable sling enhances early continence after radical prostatectomy
High IL-6 levels tied to low hemoglobin in ovarian cancer
ZAC gene silencing tied to ovarian cancer progression
June 2005
Short-term oral contraceptive use decreases ovarian cancer risk
Echovirus type 1 effective in ovarian cancer model
Psychosocial support linked to lower IL-6 levels with ovarian cancer
May 2005
Anti-MUC1 antibodies may protect against ovarian cancer
MRI technique helps track ovarian cancer therapy
Moderate activity may reduce ovarian cancer risk
Serum protein panel accurately detects early ovarian cancer
April 2005
Lymphadenectomy in ovarian cancer does not prolong survival
Genistein may help overcome cisplatin-resistance in ovarian cancer
Routine appendectomy indicated during surgical staging of ovarian cancer
February 2005
Conservative surgery for ovarian tumors spares fertility
Increased clusterin in ovarian cancer linked to tumor aggression
January 2005
"Kissing ovaries" a sign of severe endometriosis
Histone deacetylase inhibitors active against ovarian cancer cells
Progesterone receptor gene mutants associated with ovarian cancer
December 2004
Gene expression profile accurately predicts ovarian cancer outcome
Additional surgical debulking no help in ovarian cancer survival
NICE issues preliminary recommendations on ovarian cancer drugs
November 2004
Ovarian cancer risk increases with cumulative oral estrogen intake
Heterotopic ovary transplant maintains hormonal function
October 2004
New model better predicts genetic risk of breast and ovarian cancer
Ovarian radioablation aids breast cancer therapy
September 2004
Teenage girls urged to visit gynecologist before Pap testing begins
Chemotherapy improves survival of stage I ovarian cancer
Transplant of cryopreserved ovarian tissue leads to live birth
Oncogene hypermethylation in serum DNA indicates early-stage ovarian cancer
CA-125 blood test best for predicting outcome of ovarian cancer
Glycoprotein detects early-stage ovarian cancer
IVF may be safe after treatment for borderline ovarian tumor
August 2004
Molecular markers help detect early ovarian cancer
T cell subset fosters ovarian tumor growth
Endometriosis, primary infertility tied to increase risk for ovarian cancer
Increased diesel exhaust exposure increases risk of ovarian cancer
July 2004
Delaying pregnancy lowers risk of ovarian cancer
Lysophosphatidic acid may point to early ovarian cancer
June 2004
First woman pregnant after ovarian transplant
Fertility drugs not tied to greatly increased risk of ovarian cancer
Study finds that symptoms precede diagnosis of ovarian cancer
Preventive Services Task Force recommends against routine ovarian cancer screening
Ovarian cancer surgery in Maryland often performed by inexperienced surgeons
May 2004
Loss of gene promotes human ovarian carcinoma
Blood test shows promise in ovarian cancer
April 2004
Frequent, vigorous activity may up the risk of ovarian cancer in older women
Childhood tumors not increased after maternal ovarian stimulation
March 2004
Human kallikrein 8 predicts a favorable outcome in ovarian cancer
High dietary folate intake linked to decreased risk of ovarian cancer
January 2004
Response to 9-AC as second-line treatment of ovarian cancer modest
Thrombocytosis linked to disease progression in advanced ovarian cancer
"Absolute survival benefit" best conveys risk and benefits of chemotherapy
December 2003
Predictors of occult metastasis of germ cell tumor identified
November 2003
Overexpressed protein may disrupt BRCA2 in sporadic breast, ovarian cancers
September 2003
Surgery at teaching hospital may improve survival for advanced ovarian cancer
Rare ovarian tumor reported in teen with transgenerational DES exposure
August 2003
Height and BMI in adolescence tied to ovarian cancer risk
July 2003
CA 125-targeted immunotherapy may prolong survival in ovarian cancer
Gynecologic surgery may protect BRCA carriers against ovarian cancer
Ovarian and adrenal venous catheterization and sampling should be limited
New marker could improve diagnosis of ovarian cancer
June 2003
Human kallikrein 8 identified as an ovarian cancer marker
Zeltia's Yondelis shows promise in ovarian cancer
Paclitaxel plus platinum improves survival in relapsed ovarian cancer
May 2003
Endometrial and ovarian cancer often associated
Lysophosphatidic acid uses cyclin D1 to stimulate ovarian cancer growth
Return of ovarian function after osteosarcoma chemotherapy common
Better survival noted in ovarian cancer patients with BRCA mutations
April 2003
Combined IP/IV chemotherapy ups survival in advanced ovarian cancer
Ovarian cancer cells overexpress collagen to resist chemotherapeutic drugs
Phenoxodiol induces apoptosis in chemoresistant ovarian cancer cells
Demethylation of ovarian cancer gene leads to cisplatin resistance
March 2003
Murine model of epithelial ovarian cancer developed
Mutations in low-grade serous ovarian cancer suggest target for therapy
Incessant ovulation may increase risk of ovarian cancer
February 2003
Fertility preserved in most women with malignant germ cell ovarian tumors
BRCA2 N372H polymorphism linked to small increased risk of ovarian cancer
January 2003
UK updates advice for using Taxol in ovarian cancer
Gemcitabine-cisplatin regimen successful for relapsed ovarian cancer
Ovarian cancer survival markedly better when tumors show T cell infiltration
Post-op chemotherapy improves outcomes of early ovarian cancer
Bristol-Myers' Taxol set to lose first choice rating in UK for ovarian cancer
Ovarian stimulation with tamoxifen may preserve fertility in breast cancer patients
December 2002
Potential early biomarkers of ovarian cancer identified
After stopping oral contraceptives, protection against ovarian cancer persists
November 2002
Dose-dense cisplatin plus paclitaxel effective in advanced ovarian cancer
Refractory ovarian cancer responds to microtubule inhibitor in phase II trial
Anti-cancer compound sensitizes ovarian tumors to cisplatin
October 2002
Chemotherapy targeted to endometrial, ovarian cancers more effective, less toxic
Elevated IGF-1 linked to risk of ovarian cancer in younger women
CXCR4 receptor antagonist inhibits ovarian cancer stimulation by chemokine
Apoptotic agent yields favourable results in ovarian cancer
September 2002
Calcium intake may lower ovarian cancer risk
August 2002
Ovarian cancer risk in young breast cancer patients increased with family history
Secondary surgery predicts survival in recurrent micropapillary serous ovarian cancer
HRT use added to risk factors for epithelial ovarian cancer
Carboplatin monotherapy may be option for first-line ovarian cancer therapy
Excess weight in adolescence linked to ovarian cancer
July 2002
Calcium intake from dairy products linked to reduced ovarian cancer risk
Long-term estrogen replacement therapy linked to increased ovarian cancer risk
May 2002
Conservative surgery safely preserves fertility in some cases of ovarian cancer
CT scan scoring model predicts resectability in ovarian cancer
Experimental test shows promise for detecting ovarian, endometrial cancers
April 2002
Successful intersibling whole ovary transplantation reported from China
New biomarkers for ovarian, breast, and head and neck cancers identified
Gynecologic abnormalities common among women with rectal cancer
HRT may pose modest increase in ovarian cancer risk in postmenopausal women
March 2002
Paclitaxel continuation extends disease-free survival in advanced ovarian cancer
Danazol use for endometriosis linked to ovarian cancer risk
African-American ovarian cancer patients at increased risk for death
February 2002
Defined genetic changes create murine model of ovarian cancer
Ovarian hyperstimulation for IVF does not increase cancer risk
BRCA mutations tied to improved survival in ovarian cancer patients
NICE recommends Schering-Plough's Caelyx for advanced ovarian cancer
Serum protein profiling may allow early detection of ovarian cancer
January 2002
Cisplatin, etoposide "highly effective" in ovarian cancer studies
Infertility drug use not linked to ovarian cancer risk
Loss of heterozygosity in BRCA1 gene predicts mutation status of ovarian tumors
Progestin largely responsible for OC's anti-ovarian cancer effect
December 2001
LMW heparin or compression both prevent thromboembolism after gynecologic surgery
Conservative surgery for borderline ovarian tumors safe, preserves fertility
November 2001
Rise in UK ovarian cancer cases prompts call for action
CA-125 doubling predicts ovarian cancer progression when levels remain high
Antioxidants do not protect against ovarian cancer
October 2001
MGI Pharma to expand enrollment in phase II ovarian cancer trial
Diet rich in carotenoids may reduce ovarian cancer risk
September 2001
Ovarian autotransplantation may preserve fertility in cancer patients
Biomarkers could aid in evaluation of new ovarian cancer therapies
Red meat consumption associated with increased risk of ovarian cancer
August 2001
Ovulation induction safe following conservative treatment of borderline ovarian tumor
Symptoms associated with ovarian cancer may allow earlier diagnosis
July 2001
OCs do not reduce ovarian cancer risk in women with BRCA mutations
Pegylated doxorubicin comparable to topotecan for recurrent ovarian cancer
Hyperthermia overcomes platinum resistance in ovarian cancer
Minilaparotomy is a feasible approach for colon cancer resection
May 2001
Tubal ligation linked to reduced risk of ovarian cancer in high-risk women
Nitrates in water linked to increased bladder and ovarian cancer risk in older women
Suppression of IL-6 might improve chemotherapy for ovarian cancer patients
March 2001
Temporary ovarian suppression may prevent chemotherapy-induced infertility
Progestin may protect against ovarian cancer through TGF-beta mediation
January 2001
Alza's Caelyx approved in Canada for refractory ovarian cancer
Degree of differentiation predicts survival in invasive epithelial ovarian cancer
November 2000
Promising new compound protects ovaries against chemotherapy, radiation
September 2000
P53 gene therapy shows promise in ovarian cancer
Ovarian cancer prognosis better in women with history of breast cancer
Induction of apoptosis may explain protective effect of OCs against ovarian cancer
Fused ovarian cancer and dendritic cells stimulate T-cell response against tumor
Dendritic cells pulsed with ovarian cancer peptides stimulate specific CTL response
August 2000
Transvaginal ultrasonography screening detects early-stage ovarian cancer
July 2000
Levels of soluble Fas elevated in women with ovarian cancer
Low-dose oral contraceptives effective in reducing ovarian cancer risk
Conservative surgery for malignant ovarian germ cell tumors preserves fertility
Undetectable genetic mutations appear to increase risk of ovarian/breast cancers
Alza ovarian cancer drug recommended for EU approval
June 2000
FDA approves new Taxol regimen for treating ovarian cancer
May 2000
Bleomycin, etoposide, and cisplatin an effective regimen for ovarian tumors
Doxorubicin better tolerated by ovarian cancer patients than topotecan
NICE recommends use of taxanes for treatment of ovarian cancer
new gold standard for advanced ovarian cancer
BRCA mutations associated with longer survival in ovarian cancer patients
April 2000
Identifiable factors account for half of ovarian cancers
AltaRex receives patent allowance for ovarian cancer treatment
Copolymer-bound doxorubicin shows potent activity in ovarian cancer model
Conservative surgery for borderline ovarian tumors confirmed to preserve fertility
March 2000
Removal of benign ovarian cysts does not lower risk of death from ovarian cancer
OCs may protect against ovarian cancer in part via direct antiandrogen effects
February 2000
Deep venous thrombosis prophylaxis cost-effective for gynecologic cancer surgery patients
Low-dose topotecan effective, less toxic in refractory ovarian cancer
Fertility-sparing surgery effective in patients with stage I ovarian cancer
January 2000
Cisplatin and paclitaxel for ovarian cancer effective, less toxic than cisplatin alone
December 1999
Ovarian tumor index predicts malignancy
Novel cadherin antagonist kills ovarian tumor cells in mice
November 1999
Stage III ovarian cancer survival better in women treated by gynecologic oncologists
October 1999
National Cancer Institute to provide $29 million for ovarian cancer research
No association detected between fertility drugs and ovarian cancer
September 1999
Details on first ovarian tissue autotransplantation reported
Photoimmunotherapy enhances cytotoxicity of cisplatin in human ovarian cancer cells ex vivo
New treatment approach spares fertility in most women with ovarian germ cell tumors
August 1999
Atairgin, Northwestern University to develop ovarian cancer test
Women with ovarian, endometrial cancers at increased risk of colorectal cancer
July 1999
Lactose absorption linked to ovarian cancer
June 1999
FDA expands doxorubicin indication to include refractory ovarian cancer
Randomized trial of gene therapy for ovarian cancer to begin at UCLA
Minilaparotomy feasible for outpatient management of ovarian cysts
FDA advisory committee backs approval of doxorubicin for ovarian cancer
May 1999
OC use recommended for women with family history of ovarian cancer
April 1999
Fertility drugs do not increase risk of breast, ovarian cancer
FDA will expedite review of Doxil for ovarian cancer
Ovarian cancer screening at greater than 1-year intervals unlikely to detect early-stage disease
Ovarian cancer screening may improve survival rates
March 1999
Adjuvant chemo prevents relapse of stage I testicular nonseminomatous germ cell tumor
Breast cancer diagnosis before age 50 increases risk of later ovarian cancer diagnosis
Hereditary ovarian cancers rare in women of childbearing age
Combination therapy revisited for advanced ovarian cancer
February 1999
Tamoxifen linked to ovarian cyst formation in premenopausal breast cancer patients
BRCA1/2 gene mutations unrelated to survival in women with breast or ovarian cancers
January 1999
Tumor stage influences recurrence risk in platinum-treated ovarian cancer
Age, race, geography influence risk of ovarian cancer mortality in US
Maternally-imprinted tumor suppressor gene in breast and ovarian cancers identified